Published in Biotech Business Week, February 21st, 2005
Under this agreement, GN Otometrics will market and distribute Natus' newly acquired line of hearing screening devices from the company's recent acquisition of Fischer-Zoth Diagnosesysteme, GmbH. This product line will be marketed in over 50 countries under the AccuScreen brand name. In addition, GN Otometrics will distribute Natus' well-known line of ALGO newborn hearing screeners in selected countries.
Jim Hawkins, president and chief executive officer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.